EuBiologics Co.,Ltd

125 Wonmudong-gil, Dongsan-myeon, Chuncheon, Gangwon, South Korea

Also known as:

eubiologics co.,ltd_chuncheon 2 nd factory co., ltd.

u bio logics (branch) co., ltd.

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

56.3%

Phase 3

31.3%

Phase 2

12.5%

Trial Status Distribution

Active, not recruiting

12.5%

Completed

75.0%

Not yet recruiting

6.3%

Recruiting

6.3%

Clinical Trials

Trials sponsored by this organization (16)

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

Phase 1

Active, not recruiting

interventional

Jul 202472 participants

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Phase 1

Active, not recruiting

interventional

May 2024100 participants

CVIA 106 - Phase 2/3 study of the EuBiologics pentavalent meningococcal ACWYX conjugate vaccine compared to MENVEO® or Nimenrix ® in healthy children through adults

Phase 2

Not yet recruiting

interventional

Apr 20244,236 participants

Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Phase 1

Completed

interventional

Feb 202360 participants

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Phase 3

Completed

interventional

Oct 20222,600 participants

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

Phase 3

Completed

interventional

Jul 20222,852 participants

CVIA 092Short Title: Phase 3 EuTCV Trial in Africa

Phase 3

Recruiting

interventional

Aug 20213,255 participants

Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

Phase 1

Completed

interventional

Feb 2021279 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations